Alina M. Allen, MD
Biography
Alina M. Allen, M.D.,M.S. is Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where she serves as the Director of Hepatology and Director of the MASLD Clinic. She is a physician scientist with an NIH-funded research program focused on improving outcomes in patients with metabolic dysfunction associated steatotic liver disease (MASLD). Her areas of expertise include noninvasive imaging biomarker development for MASH; individualized prediction of future development of cirrhosis and complications using state-of-the-art imaging technologies; population-based research using large data sets to disentangle the epidemiologic associations between MASLD, cirrhosis, metabolic syndrome, cardiovascular disease and cancer risk. She is a co-principal investigator of the Data Analytics and AI for Advanced Liver Disease at Mayo Clinic, where she uses artificial intelligence methods to develop predictive models in MASLD and disease trajectories. Dr. Allen is an Associate Editor of Hepatology and vice-chair of the MASLD Special Interest Group within the American Association for the Study for Liver Diseases.
Sessions
1:00 PM
- 12:30 PM
Convention Center - Bluebird Ballroom 2ABC
Obesity Medicine Course, Parts 1 and 2: Obesity and the Liver—From Metabolic Dysfunction–Associated Steatotic Liver Disease to Cardiovascular-Kidney-Liver-Metabolic Diseases (Ticketed)
Amreen Dinani, MD FRCPC | Moderator,
Arun Sanyal, MD, FAASLD | Presenter,
Fernando Bril, MD | Presenter,
Silvia Vilarinho, MD, PhD | Moderator,
Mitchell A Mah'moud, MD, FACG, AGAF, FAASLD | Moderator,
Cynthia A Moylan, MD, MHS, FAASLD | Presenter,
Jaime Chu, MD, FAASLD | Presenter,
Amreen Dinani, MD FRCPC | Chair,
Mitchell A Mah'moud, MD, FACG, AGAF, FAASLD | Chair,
Alina M. Allen, MD | Moderator,
Anna Mae E Diehl, MD, FAASLD | Presenter,
Alina M. Allen, MD | Presenter,
Wajahat Z Mehal, MD, FAASLD | Presenter,
Zobair M Younossi, MD, MPH, FAASLD | Presenter
11:00 AM
- 8:30 AM
Convention Center - Bluebird Ballroom 1A
The Metabolic Dysfunction–Associated Steatotic Liver Disease and Hepatocellular Carcinoma Continuum: Fibrosis, Inflammation, and Clinical Decision-Making, Part 1
Vincent WS Wong, MD | Presenter,
Lisa VanWagner, MD | Presenter,
Alina M. Allen, MD | Moderator,
Amreen Dinani, MD FRCPC | Moderator,
Alina M. Allen, MD | Chair,
Amreen Dinani, MD FRCPC | Chair,
Anna Mae E Diehl, MD, FAASLD | Presenter,
Hashem B El-Serag, MD, MPH | Presenter
12:45 PM
- 9:30 AM
Convention Center - Room 1B
MTE #16: Hidden in the Chart—Leveraging the Electronic Health Records to Detect Fibrotic Metabolic Dysfunction–Associated Steatohepatitis (Ticketed)
Sujit Janardhan, MD, PhD, Dipl ABOM | Discussion Leader,
Alina M. Allen, MD | Discussion Leader
12:45 PM
- 9:30 AM
Convention Center - Room 1A
MTE #29: Seeing Through the Haze—Mastering Noninvasive Tools for Fibrotic Metabolic Dysfunction–Associated Steatohepatitis (Ticketed)
Amreen Dinani, MD FRCPC | Discussion Leader,
Alina M. Allen, MD | Discussion Leader
